fbpx

Check out the latest episodes of our Life Science and Food Industry Podcasts. Available everywhere!

X

Skip to content
  • LOGIN
  • JOIN
Xtalks
  • Webinars
  • Industries
    • Food
    • Medical Devices
    • Life Sciences
      • Peer Circles
  • Editorial
    • All Vitals
    • News
    • Blogs
    • Videos
    • Life Science Podcast
    • Food Industry Podcast
    • Quizzes & Polls
    • COVID-19 Coverage
  • Why host a webinar?
    • Contact Us to Host Your Webinars
    • Learn More
    • Webinar Production & Marketing Tips
  • Industry Jobs
    • Search Jobs
    • Post Job
    • Career Insights
  • About Us
    • Frequently Asked Questions
    • Team
    • Join Xtalks
  • Contact
  • Webinars
  • Industries
    • Food
    • Medical Devices
    • Life Sciences
      • Peer Circles
  • Editorial
    • All Vitals
    • News
    • Blogs
    • Videos
    • Life Science Podcast
    • Food Industry Podcast
    • Quizzes & Polls
    • COVID-19 Coverage
  • Why host a webinar?
    • Contact Us to Host Your Webinars
    • Learn More
    • Webinar Production & Marketing Tips
  • Industry Jobs
    • Search Jobs
    • Post Job
    • Career Insights
  • About Us
    • Frequently Asked Questions
    • Team
    • Join Xtalks
  • Contact

Designing and Conducting Effective Long-term Follow-Up Studies

Life Sciences, Clinical Trials, Pharmaceutical, Drug Discovery & Development,
  • Monday, July 19, 2021 | 11am EDT (NA) / 4pm BST (UK) / 5pm CEST (EU-Central)
  • 60 min
  • Register
  • Description
  • Speakers
  • Who Should Attend?
  • Partners
  • Register

Share this:

  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Reddit (Opens in new window)
  • Click to email a link to a friend (Opens in new window)

Clinical trials often include an extended post-study follow–up period, ranging anywhere from months to years to assess the long-term impact of the treatment. Long-term follow up (LTFU) studies are undertaken to address the needs of the scientific community, regulators or both. The LTFU phase of a study has traditionally been part of a single clinical trial, but we are now seeing a decoupling of this phase into a stand-alone study.

While stand-alone LTFU studies are not new, the models have evolved with the advent of potentially transformative therapies and treatments, including, but not limited to advanced therapy medical products, cellular products and gene therapies. Sponsors are showing more interest in this specific type of study given new regulatory requirements, which in some cases call for 15 years of monitoring of patient outcomes and safety.

Register for this webinar to explore:

  • Various models of LTFU studies and their applications
  • Operational considerations to streamline the transition from clinical research to commercialisation in the current regulatory environment
Keywords:
  • Clinical Operations
  • ,
  • Real-World Evidence
  • ,
  • Regulatory Affairs
  • ,
  • Cell and Gene Therapies
  • ,
  • Long-Term Follow-Up Studies
Register

Speakers

http://Brandon%20Fletcher,%20ICON

Brandon Fletcher, Cell and Gene Therapy Principal, ICON

Brandon is a Biochemist and Cancer Immunologist with roughly 30 years of research experience, specializing in hematology-oncology, rare disease and infectious disease. She has held roles in broad immune-oncology and cell and gene therapy research within academia and industry. Brandon is a collaborator with NCI’s origination of cancer CGTs and co-founded a global immune-oncology research training and support organization.

Message Presenter
http://M.%20Christina%20Haas,%20ICON

M. Christina Haas, Director, Project Management, Real World Evidence Late Phase Research, ICON

Chris joined ICON in 2004 and is field-based near Munich, Germany and has held the position of Director, Project Management, Real World Evidence Late Phase Research, since 2013. Chris is responsible for providing Project Director oversight and governance to teams that manage, organize, and implement global late phase projects; overseeing managers that lead multidisciplinary cross-functional project teams from study start-up through to final product deliverable; and facilitating communications with clients. She has more than 24 years of experience in clinical research (phases II-IV) in both interventional and non-interventional studies on a global scale.

Message Presenter

Message Presenter

Have questions or would like more information? Use the form below to send a message.

Who Should Attend?

This program will be beneficial for pharmaceutical, medical device and biotechnology professionals working in the following areas:

  • Clinical research
  • Clinical development
  • Patient outcomes
  • Real-world evidence
  • Cell and gene therapies

What You Will Learn

In this webinar, participants will learn about:

  • Various models of LTFU studies and their applications
  • Operational considerations to streamline the transition from clinical research to commercialisation in the current regulatory environment

Xtalks Partner

ICON

ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON will operate from 150 locations in 47 countries and have approximately 38,000 employees as of July 1, 2021.

Related Webinars

March 17, 2022

A Guide to Conducting Clinical Trials in China

A Guide to Conducting Clinical Trials in China
March 25, 2022

Hot Flashes, Brain Fog and the Blues: Frontiers in Menopause Treatments

Hot Flashes, Brain Fog and the Blues: Frontiers in Menopause Treatments
February 08, 2022

Longitudinal Qualitative Research: A Powerful Tool for Patient-centred Research

Longitudinal Qualitative Research: A Powerful Tool for Patient-centred Research
November 29, 2021

What is the Link Between Pharmacovigilance and Building Confidence Around COVID-19 Vaccines?

What is the Link Between Pharmacovigilance and Building Confidence Around COVID-19 Vaccines?
November 15, 2021

ICON’s World Children’s Day: Special Panel Discussion

ICON’s World Children’s Day: Special Panel Discussion

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account
Sign up for our newsletters and receive webinars, vitals and updates for your topic of choice.
Please review our privacy policy and understand that we may occasionally inform you of similar content if you press submit to subscribe to a newsletter. You may unsubscribe at anytime.

Webinars

  • All Webinars
  • Host a Webinar
  • Medical Devices
  • Food Industry
  • Life Sciences

Vitals

  • News
  • Blogs
  • Videos
  • Quizzes & Polls

Industry Jobs

  • Career Insights Blogs
  • Post a Job
  • Search Jobs

About

  • About Us
  • FAQ
  • Meet the Team
  • Contact
  • Privacy Policy
  • Terms of Use

My Xtalks

  • Login
  • My Profile
  • Edit Profile
  • Join Xtalks
  • Back To Top

Login

Already have an account at Xtalks? Login with:

Facebook

Or

Lost Password?

Don't have an account?Join

Join

Create an account for access to webinars, jobs, news, blogs, discussions and more. Join thousands of other professionals from life science, medical device and food industries.

Create an account using

Facebook

Or

Create an Account Using Your Email

Have an account? Login Here

Registration Successful

Success! You're one step away. You will have soon an email from us with account your Xtalks password and to reset your account password.

Got your password? Login Here

Copyright 2022 Honeycomb Worldwide Inc. All Rights Reserved. Site by Trew Knowledge.

Success!

You have just entered the contest
with # submissions and # point(s) spent.